Advertisement

Topics

"Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older" Drugs and Medication Database

21:18 EST 21st February 2019 | BioPortfolio

Here are the most relevant "Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older" Drugs and Medications that we have found in our database.

More Information about "Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older" on BioPortfolio

We have published hundreds of Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older news stories on BioPortfolio along with dozens of Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older Clinical Trials and PubMed Articles about Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older Companies in our database. You can also find out about relevant Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older Drugs and Medications on this site too.

Showing "Evaluation Tdap Tetanus Diphteria Pertussis Inactivated Polio Vaccination" Drugs and Medications 1–25 of 42

Probably Relevant

Tubersol [a-s medication solutions]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Tubersol [a-s medication solutions]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Tubersol [sanofi pasteur inc.]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Tubersol [physicians total care, inc.]

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Possibly Relevant

Kineret [swedish orphan biovitrum ab (publ)]

These highlights do not include all the information needed to use KINERET safely and effectively. See full prescribing information for KINERET. KINERET® (anakinra) injection, for subcutaneous useInitial U.S. Approval: 2001

Methocarbamol [general injectables and vaccines, inc.]

Methocarbamol Injection, USP 1,000 mg/10 mL (100 mg/mL)Rx Only

Methocarbamol [dr.reddy’s laboratories inc.,]

Methocarbamol Injection, USP ( For Intravenous or Intramuscular Injection)

Methocarbamol [fresenius kabi usa, llc]

NA

Methocarbamol [gland pharma limited]

Methocarbamol Injection, USP (For Intravenous or Intramuscular Injection) Rx only

Methocarbamol [auromedics pharma llc]

NA

Methocarbamol [renaissance ssa, llc]

Methocarbamol Injection

Methocarbamol [navinta llc]

METHOCARBAMOL INJECTION, USP Injectable Rx Only

Methocarbamol [american regent, inc.]

Methocarbamol Injection, USP

Robaxin [west-ward pharmaceuticals corp.]

ROBAXIN Injectable (methocarbamol injection, USP)

Methocarbamol [mylan institutional llc]

NA

Methocarbamol [meitheal pharmaceuticals inc.]

Methocarbamol Injection, USP(For intravenous or Intramuscular Use)

Methocarbamol [sagent pharmaceuticals]

Methocarbamol Injection, USP(For Intravenous or Intramuscular Use)

Robaxin [west-ward pharmaceuticals corp.]

ROBAXIN Injectable (methocarbamol injection, USP)

Methocarbamol [athenex pharmaceutical division, llc.]

Methocarbamol Injection, USP(For Intravenous or Intramuscular Injection)

Methocarbamol [somerset therapeutics, llc]

Methocarbamol Injection, USP RX only

Ocrevus [genentech, inc.]

These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 2017

Diazepam [rebel distributors corp]

DIAZEPAM Injection, USP

Diazepam [physicians total care, inc.]

NA

Diazepam [a-s medication solutions]

DIAZEPAM Injection, USP 5 mg/mL

Cnj-016 [emergent biosolutions canada inc.]

These highlights do not include all the information needed to use CNJ-016 (vaccinia immune globulin intravenous, human), VIGIV safely and effectively. See full prescribing information for VIGIV. VIGIV (vaccinia immune globulin, human), 5% sterile solution



Advertisement
Quick Search
Advertisement
Advertisement